Three Is The Magic Number: Celltrion Lines Up A Trio Of European Biosimilars
As Biocon Biologics And Aurobindo’s CuraTeQ Also Pick Up EMA Nods
Celltrion has emerged from the latest CHMP meeting at the EMA with three new biosimilars lined up for approval. At the same time, Biocon Biologics and Aurobindo’s CuraTeQ have also picked up positive opinions for biosimilars, while Neuraxpharm has won endorsements for a pair of hybrids.
